Dopaminergic system modulation, behavioral changes, and oxidative stress after neonatal administration of pyrethroids.
Pyrethroids are a class of insecticides involved in different neurological disorders. They cross the blood-brain barrier and exert their effect on dopaminergic system, contributing to the burden of oxidative stress in Parkinson's disease through several pathways. The aim of the present study was to evaluate the effect of neonatal exposition to permethrin and cypermethrin (1/10 of DL(50)) in rats from the eighth to the fifteenth day of life. Open-field studies showed increased spontaneous locomotor activity in the groups treated with permethrin and the one treated with cypermethrin, while a higher number of center entries and time spent in the center was observed for the cypermethrin-treated group. Lower dopamine and higher homovanillic acid levels were measured in the striatum from both treated groups. A reduction of blood glutathione peroxidase content was measured, while no change in blood superoxide dismutase was observed. Carbonyl group formation increased in striatum, but not in erythrocytes. Lipid peroxidation occurred in erythrocytes, but not in striatum. No changes in fluidity at different depths of plasma membrane were measured in striatum or erythrocytes. The activation of monocyte NADPH oxidase by phorbol esters (PMA) shows that superoxide anion production was reduced in the pyrethroid-treated groups compared to the control group. Our studies suggest that neonatal exposition to permethrin or cypermethrin induces long-lasting effects after developmental exposure giving changes in open-field behaviors, striatal monoamine level, and increased oxidative stress. Although the action of pyrethroids on various target cells is different, a preferential interaction with the extracellular side of plasma membrane proteins can be observed.
Nasuti
Cinzia
C
Dipartimento di Medicina Sperimentale e Sanità Pubblica, Università di Camerino, Via Scalzino, 62032 Camerino (MC), Italy. cinzia.nasuti@unicam.it
Gabbianelli
Rosita
R
Falcioni
Maria Letizia
ML
Di Stefano
Antonio
A
Sozio
Piera
P
Cantalamessa
Franco
F
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004912:Erythrocytes / Q000187:drug effects / Q000502:physiology; D005260:Female; D005978:Glutathione / Q000378:metabolism; D005979:Glutathione Peroxidase / Q000097:blood; D006719:Homovanillic Acid / Q000378:metabolism; D007306:Insecticides / Q000633:toxicity*; D008297:Male; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D018384:Oxidative Stress; D026023:Permethrin / Q000633:toxicity*; D011722:Pyrethrins / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D016897:Respiratory Burst / Q000187:drug effects; D013482:Superoxide Dismutase / Q000097:blood
D007306:Insecticides; D011722:Pyrethrins; D015102:3,4-Dihydroxyphenylacetic Acid; C017160:cypermethrin; D026023:Permethrin; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D005978:Glutathione; D004298:Dopamine; D006719:Homovanillic Acid